Antibody | Specificity | Dilution | Sources |
---|---|---|---|
c-fos (Ab-2) Polyconal (PC05) | Amonio acid residues 4–17 of human c-Fos | 1:40 | Oncogene Research Products, Cambridge, MA |
c-Jun (Ab-2) Polyclonal (PC07) | Amonio acid residues 91–105 of human c-Jun | 1:40 | Oncogene Research Products, Cambridge, MA |
Phopho-specific P44/42 MAPK polyclonal Ab (9101S) | Amonio acid residues 91–105 of human p44 MAP kinase, detects p42 and p44 MAPK (Erk1 and Erk2), only when activated by phosphorylation at Thr 202 and Tyr 204 | 1:250 | New England Biolabs, Inc. Beverly, MA |
P44/42 MAPK polyclonal Ab (9102) | Amonio acid residues 345–358 of rat p42 MAPK, detects total MAP kinase (Erk1 and Erk2) levels | 1:1000 | New England Biolabs, Inc. Beverly, MA |
Phospho-p38 MAPK polyclonal Ab (9211S) | A synthetic doubly phosphorylated peptide (Thr 180/Tyr 182) of human p38 MAPK | 1:500 | New England Biolabs, Inc. Beverly, MA |
p-JNK (G-7) Monoclonal AB (sc-6254) | A short aa sequence containing phosphorylated on Thr-183 and Tyr-185 of JNK1 of human, reacts to phosporylated JNK 1–3 | 1:250 | Santa Cruz Biotechnology, Inc. USA |
JNK2 (D-2) Monoclonal AB (sc-7345) | Full lengh (aa 1–424) human JNK2, reacts to JNK1-3 | 1:250 | Santa Cruz Biotechnology, Inc. USA |